D02248 | |
D number | D02248 |
Classification | Drug |
Name | Levomepromazine maleate (JP17/USAN); Hirnamin (TN) |
Component | - |
Formula | C19H24N2OS. C4H4O4 |
Exact mass | 444.1719 |
Mol weight | 444.5438 |
Structural formula | ![]() |
Sequence | - |
Sequence type | - |
Source | - |
Upper DGroup | Cardiovascular agent DG01466 Adrenergic receptor antagonist DG01465 alpha-Adrenergic receptor antagonist DG01457 alpha1-Adrenergic receptor antagonist DG01460 alpha2-Adrenergic receptor antagonist Neuropsychiatric agent DG01905 Phenothiazine antipsychotics DG01478 Dopamine antagonist DG01474 Dopamine D2-receptor antagonist Cyp substrate DG01644 CYP2D6 substrate Cyp inhibitor DG01645 CYP2D6 inhibitor |
Remark | Therapeutic category: 1172 ATC code: N05AA02 Chemical group: DG00868 |
Activity | - |
Disease | - |
Comment | Phenothiazine derivative |
Target | DRD2 [HSA:1813] [KO:K04145] |
Metabolism | - |
Interaction | |
Other DBs | CAS: 7104-38-3 PubChem: 7849307 ChEMBL: CHEMBL1725730 LigandBox: D02248 NIKKAJI: J231.544K |
KCF data | - |